For the year ending 2025-12-31, NHC had $15,265K increase in cash & cash equivalents over the period. $148,632K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 122,606 |
| Depreciation and amortization | 44,920 |
| Equity in earnings of unconsolidated investments | 218 |
| Distributions from unconsolidated investments | 616 |
| Unrealized gains on marketable equity securities | 22,344 |
| (gains) losses on sale of marketable securities | 1,167 |
| Gain on sale of unconsolidated company | 0 |
| Gain on sale of property and equipment | 3,606 |
| Deferred income taxes | -6,477 |
| Stockbased compensation | 4,399 |
| Accounts receivable | 3,677 |
| Inventories | -1,244 |
| Prepaid expenses and other assets | -4,574 |
| Operating lease obligations | 695 |
| Trade accounts payable | -2,726 |
| Accrued payroll | 11,198 |
| Amounts due to third party payors | -1,612 |
| Accrued risk reserves | 17,979 |
| Other current liabilities | 4,600 |
| Other noncurrent liabilities | 1,120 |
| Net cash provided by operating activities | 185,078 |
| Purchases of property and equipment | 36,446 |
| Acquisition of businesses, net of cash acquired-White Oak Senior Living Portfolio | 0 |
| Investments in unconsolidated companies | 5,629 |
| Purchases of marketable securities | 65,188 |
| Sale of marketable securities | 72,893 |
| Collections of (investments in) notes receivable | -512 |
| Acquisition of businesses, net of cash acquired-Other Business Acquisitions | 0 |
| Proceeds from sale of assets | 0 |
| Net cash used in investing activities | -33,858 |
| Borrowings under credit facility | 0 |
| Repayments under credit facility | 97,000 |
| Dividends paid to common stockholders | 38,704 |
| Issuance of common shares | 14,214 |
| Repurchase of common shares | 14,730 |
| Noncontrolling interest contributions | 150 |
| Entrance fee deposits (refunds) | 115 |
| Debt issuance costs | 0 |
| Principal payments under finance lease obligations | 0 |
| Net cash (used in) / provided by financing activities | -135,955 |
| Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents | 15,265 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period | 96,922 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period | 112,187 |
NATIONAL HEALTHCARE CORP (NHC)
NATIONAL HEALTHCARE CORP (NHC)